Table S4 from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations
收藏NIAID Data Ecosystem2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/Table_S4_from_Phase_II_Clinical_Trial_of_Everolimus_in_a_Pan-Cancer_Cohort_of_Patients_with_mTOR_Pathway_Alterations/22480319
下载链接
链接失效反馈官方服务：
资源简介：
Table S4. Inactivating mutations in TSC1/TSC2 and activating mutation in MTOR identified in 30 patients in the clinical trial - clonality and biallelic TSC1/TSC2 inactivation status.
创建时间：
2021-07-15
